Israel’s Teva has launched ALYQ – a generic form of Adcirca, to reduce the symptoms of pulmonary arterial hypertension (PAH).
https://en.globes.co.il/en/article-teva-launches-generic-pulmonary-hypertension-drug-1001272239
Treatment for pulmonary hypertension
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.